Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
13%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
HART
75
HOLDINGS
6%
ALSO IN XPH
XPH
40
HOLDINGS
10%
ALSO IN HART
SECTOR DRIFT (HART minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HART |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 5.6% | 3.8% | 3.8% |
|
PFIZER INC | 4.7% | 3.3% | 3.3% |
|
ELI LILLY & CO | 4.5% | 3.1% | 3.1% |
|
BRISTOL-MYERS SQUIBB CO | 3.9% | 3.1% | 3.1% |
HART Overweight Relative to XPH
|
ALPHABET INC. CLASS A | 6.8% |
 |
NOVARTIS AG | 6.0% |
 |
ASTRAZENECA PLC | 5.9% |
|
BOSTON SCIENTIFIC CORP | 5.8% |
|
ABBOTT LABORATORIES | 5.5% |
 |
MEDTRONIC PLC | 5.3% |
|
APPLE INC | 4.9% |
 |
SANOFI-AVENTIS | 3.2% |
|
NIKE INC -CL B | 2.6% |
 |
NOVO NORDISK A/S-B | 2.5% |
HART Underweight Relative to XPH
|
ELANCO ANIMAL HEALTH, INC. | -4.3% |
|
TARSUS PHARMACEUTICALS, INC. | -4.0% |
|
JAZZ PHARMACEUTICALS PLC | -3.8% |
|
VIATRIS, INC. | -3.7% |
|
AXSOME THERAPEUTICS, INC. | -3.7% |
|
ROYALTY PHARMA PLC CLASS A | -3.6% |
|
ORGANON & CO. | -3.5% |
|
MERCK & CO. INC. | -3.5% |
|
CORCEPT THERAPEUTICS INC | -3.4% |
|
BIOSANTE PHARMACEUTICALS INC | -3.2% |